- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x GX0: 1-[(4-chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)benzimidazole(Non-covalent)
- 4 x PTY: PHOSPHATIDYLETHANOLAMINE(Non-covalent)
PTY.2: 13 residues within 4Å:- Chain A: W.434, W.435, M.438, I.484, I.487, L.488, L.491, Q.507, L.514
- Chain D: T.603, T.607
- Ligands: POV.3, YZY.7
9 PLIP interactions:7 interactions with chain A, 2 interactions with chain D- Hydrophobic interactions: A:I.484, A:I.487, A:L.488, A:L.491, A:L.514, D:T.603, D:T.607
- Hydrogen bonds: A:W.434, A:Q.507
PTY.9: 13 residues within 4Å:- Chain A: T.603, T.607
- Chain B: W.434, W.435, M.438, I.484, I.487, L.488, L.491, Q.507, L.514
- Ligands: POV.10, YZY.14
9 PLIP interactions:7 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:I.484, B:I.487, B:L.488, B:L.491, B:L.514, A:T.603, A:T.607
- Hydrogen bonds: B:W.434, B:Q.507
PTY.16: 13 residues within 4Å:- Chain B: T.603, T.607
- Chain C: W.434, W.435, M.438, I.484, I.487, L.488, L.491, Q.507, L.514
- Ligands: POV.17, YZY.21
9 PLIP interactions:2 interactions with chain B, 7 interactions with chain C- Hydrophobic interactions: B:T.603, B:T.607, C:I.484, C:I.487, C:L.488, C:L.491, C:L.514
- Hydrogen bonds: C:W.434, C:Q.507
PTY.23: 13 residues within 4Å:- Chain C: T.603, T.607
- Chain D: W.434, W.435, M.438, I.484, I.487, L.488, L.491, Q.507, L.514
- Ligands: POV.24, YZY.28
9 PLIP interactions:7 interactions with chain D, 2 interactions with chain C- Hydrophobic interactions: D:I.484, D:I.487, D:L.488, D:L.491, D:L.514, C:T.603, C:T.607
- Hydrogen bonds: D:W.434, D:Q.507
- 4 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.3: 9 residues within 4Å:- Chain A: S.444, L.445, A.448, W.472, I.477, L.481, I.484
- Chain D: F.596
- Ligands: PTY.2
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:L.445, A:A.448, A:L.481, A:I.484, A:I.484
- Hydrogen bonds: A:W.472
POV.10: 9 residues within 4Å:- Chain A: F.596
- Chain B: S.444, L.445, A.448, W.472, I.477, L.481, I.484
- Ligands: PTY.9
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:L.445, B:A.448, B:L.481, B:I.484, B:I.484
- Hydrogen bonds: B:W.472
POV.17: 9 residues within 4Å:- Chain B: F.596
- Chain C: S.444, L.445, A.448, W.472, I.477, L.481, I.484
- Ligands: PTY.16
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:L.445, C:A.448, C:L.481, C:I.484, C:I.484
- Hydrogen bonds: C:W.472
POV.24: 9 residues within 4Å:- Chain C: F.596
- Chain D: S.444, L.445, A.448, W.472, I.477, L.481, I.484
- Ligands: PTY.23
6 PLIP interactions:6 interactions with chain D- Hydrophobic interactions: D:L.445, D:A.448, D:L.481, D:I.484, D:I.484
- Hydrogen bonds: D:W.472
- 4 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.4: 13 residues within 4Å:- Chain A: W.315, Y.316, F.364, F.367, T.371, L.375, L.496, F.497, A.499, N.500
- Chain D: F.522, C.525, L.526
11 PLIP interactions:7 interactions with chain A, 4 interactions with chain D- Hydrophobic interactions: A:F.367, A:T.371, A:L.375, A:F.497, A:F.497, A:A.499, D:F.522, D:F.522, D:F.522, D:L.526
- Hydrogen bonds: A:N.500
Y01.11: 13 residues within 4Å:- Chain A: F.522, C.525, L.526
- Chain B: W.315, Y.316, F.364, F.367, T.371, L.375, L.496, F.497, A.499, N.500
11 PLIP interactions:7 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:F.367, B:T.371, B:L.375, B:F.497, B:F.497, B:A.499, A:F.522, A:F.522, A:F.522, A:L.526
- Hydrogen bonds: B:N.500
Y01.18: 13 residues within 4Å:- Chain B: F.522, C.525, L.526
- Chain C: W.315, Y.316, F.364, F.367, T.371, L.375, L.496, F.497, A.499, N.500
11 PLIP interactions:7 interactions with chain C, 4 interactions with chain B- Hydrophobic interactions: C:F.367, C:T.371, C:L.375, C:F.497, C:F.497, C:A.499, B:F.522, B:F.522, B:F.522, B:L.526
- Hydrogen bonds: C:N.500
Y01.25: 13 residues within 4Å:- Chain C: F.522, C.525, L.526
- Chain D: W.315, Y.316, F.364, F.367, T.371, L.375, L.496, F.497, A.499, N.500
11 PLIP interactions:7 interactions with chain D, 4 interactions with chain C- Hydrophobic interactions: D:F.367, D:T.371, D:L.375, D:F.497, D:F.497, D:A.499, C:F.522, C:F.522, C:F.522, C:L.526
- Hydrogen bonds: D:N.500
- 4 x ZN: ZINC ION(Non-covalent)
ZN.5: 4 residues within 4Å:- Chain A: H.172, C.176, C.178, C.181
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:H.172, A:C.176, A:C.178, A:C.181
ZN.12: 4 residues within 4Å:- Chain B: H.172, C.176, C.178, C.181
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:H.172, B:C.176, B:C.178, B:C.181
ZN.19: 4 residues within 4Å:- Chain C: H.172, C.176, C.178, C.181
4 PLIP interactions:4 interactions with chain C- Metal complexes: C:H.172, C:C.176, C:C.178, C:C.181
ZN.26: 4 residues within 4Å:- Chain D: H.172, C.176, C.178, C.181
4 PLIP interactions:4 interactions with chain D- Metal complexes: D:H.172, D:C.176, D:C.178, D:C.181
- 4 x CA: CALCIUM ION(Non-covalent)
CA.6: 5 residues within 4Å:- Chain A: E.418, E.421, N.436, D.439, R.492
2 PLIP interactions:2 interactions with chain A- Metal complexes: A:E.418, A:D.439
CA.13: 5 residues within 4Å:- Chain B: E.418, E.421, N.436, D.439, R.492
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:E.418, B:D.439
CA.20: 5 residues within 4Å:- Chain C: E.418, E.421, N.436, D.439, R.492
2 PLIP interactions:2 interactions with chain C- Metal complexes: C:E.418, C:D.439
CA.27: 5 residues within 4Å:- Chain D: E.418, E.421, N.436, D.439, R.492
2 PLIP interactions:2 interactions with chain D- Metal complexes: D:E.418, D:D.439
- 4 x YZY: (2S)-2-(hexadecanoyloxy)-3-hydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
YZY.7: 17 residues within 4Å:- Chain A: L.514, L.521, Y.524, L.528, F.569, Q.573, F.576, W.577, V.579
- Chain D: F.599, A.602, T.603, T.607, V.610, I.611, L.616
- Ligands: PTY.2
13 PLIP interactions:9 interactions with chain A, 4 interactions with chain D- Hydrophobic interactions: A:L.514, A:L.521, A:Y.524, A:F.569, A:Q.573, A:F.576, A:V.579, D:V.610, D:V.610, D:I.611, D:L.616
- Hydrogen bonds: A:Q.573, A:W.577
YZY.14: 17 residues within 4Å:- Chain A: F.599, A.602, T.603, T.607, V.610, I.611, L.616
- Chain B: L.514, L.521, Y.524, L.528, F.569, Q.573, F.576, W.577, V.579
- Ligands: PTY.9
13 PLIP interactions:9 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:L.514, B:L.521, B:Y.524, B:F.569, B:Q.573, B:F.576, B:V.579, A:V.610, A:V.610, A:I.611, A:L.616
- Hydrogen bonds: B:Q.573, B:W.577
YZY.21: 17 residues within 4Å:- Chain B: F.599, A.602, T.603, T.607, V.610, I.611, L.616
- Chain C: L.514, L.521, Y.524, L.528, F.569, Q.573, F.576, W.577, V.579
- Ligands: PTY.16
13 PLIP interactions:9 interactions with chain C, 4 interactions with chain B- Hydrophobic interactions: C:L.514, C:L.521, C:Y.524, C:F.569, C:Q.573, C:F.576, C:V.579, B:V.610, B:V.610, B:I.611, B:L.616
- Hydrogen bonds: C:Q.573, C:W.577
YZY.28: 17 residues within 4Å:- Chain C: F.599, A.602, T.603, T.607, V.610, I.611, L.616
- Chain D: L.514, L.521, Y.524, L.528, F.569, Q.573, F.576, W.577, V.579
- Ligands: PTY.23
13 PLIP interactions:9 interactions with chain D, 4 interactions with chain C- Hydrophobic interactions: D:L.514, D:L.521, D:Y.524, D:F.569, D:Q.573, D:F.576, D:V.579, C:V.610, C:V.610, C:I.611, C:L.616
- Hydrogen bonds: D:Q.573, D:W.577
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Song, K. et al., Structural basis for human TRPC5 channel inhibition by two distinct inhibitors. Elife (2021)
- Release Date
- 2021-03-31
- Peptides
- Short transient receptor potential channel 5: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x GX0: 1-[(4-chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)benzimidazole(Non-covalent)
- 4 x PTY: PHOSPHATIDYLETHANOLAMINE(Non-covalent)
- 4 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 4 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 4 x ZN: ZINC ION(Non-covalent)
- 4 x CA: CALCIUM ION(Non-covalent)
- 4 x YZY: (2S)-2-(hexadecanoyloxy)-3-hydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Song, K. et al., Structural basis for human TRPC5 channel inhibition by two distinct inhibitors. Elife (2021)
- Release Date
- 2021-03-31
- Peptides
- Short transient receptor potential channel 5: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.